Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 3:56 pm Sale |
2024-12-31 | 13G | Climb Bio, Inc. CLYM |
BML Investment Partners, L.P. | 0 0.000% |
-2,350,682 (Position Closed) |
Filing History |
| 2024-11-14 09:29 am Sale |
2024-09-30 | 13G | Climb Bio, Inc. CLYM |
Deep Track Capital, LP | 2,169,143 3.230% |
-1,735,642 (-44.45%) |
Filing History |
| 2024-08-16 4:23 pm Unchanged |
2024-08-14 | 13D | Climb Bio, Inc. CLYM |
AI ETI LLC | 5,009,400 7.500% |
0 (Unchanged) |
Filing History |
| 2024-08-14 4:05 pm Purchase |
2024-06-30 | 13G | Climb Bio, Inc. CLYM |
Affinity Healthcare Fund, LP | 1,813,193 2.700% |
143,193 (+8.57%) |
Filing History |
| 2024-07-02 4:01 pm Purchase |
2024-06-27 | 13G | Climb Bio, Inc. CLYM |
Deep Track Capital, LP | 3,904,785 5.850% |
3,904,785 (New Position) |
Filing History |
| 2024-07-01 9:28 pm Purchase |
2024-06-27 | 13D | Climb Bio, Inc. CLYM |
RA Capital Management, L.P. | 31,459,267 47.100% |
18,268,418 (+138.49%) |
Filing History |
| 2024-06-06 4:16 pm Purchase |
2024-06-04 | 13D | Climb Bio, Inc. CLYM |
RA Capital Management, L.P. | 13,190,849 44.300% |
557 (+0.00%) |
Filing History |
| 2024-05-17 4:18 pm Purchase |
2024-05-15 | 13D | Climb Bio, Inc. CLYM |
RA Capital Management, L.P. | 13,190,292 45.300% |
556 (+0.00%) |
Filing History |
| 2024-05-17 4:01 pm Unchanged |
2024-05-15 | 13D | Climb Bio, Inc. CLYM |
AI ETI LLC | 5,009,400 17.200% |
0 (Unchanged) |
Filing History |
| 2024-05-07 6:01 pm Purchase |
2024-05-01 | 13G | Climb Bio, Inc. CLYM |
Affinity Healthcare Fund, LP | 1,670,000 6.020% |
1,670,000 (New Position) |
Filing History |
| 2024-04-12 6:52 pm Purchase |
2024-04-10 | 13D | Climb Bio, Inc. CLYM |
RA Capital Management, L.P. | 13,189,736 47.500% |
10,555 (+0.08%) |
Filing History |
| 2024-03-18 4:46 pm Purchase |
2024-03-14 | 13D | Climb Bio, Inc. CLYM |
RA Capital Management, L.P. | 13,179,181 47.500% |
2,778 (+0.02%) |
Filing History |
| 2024-02-07 11:53 am Purchase |
2023-12-31 | 13G | Climb Bio, Inc. CLYM |
BML Investment Partners, L.P. | 2,350,682 8.500% |
453,068 (+23.88%) |
Filing History |
| 2023-11-17 4:30 pm Purchase |
2023-11-15 | 13D | Climb Bio, Inc. CLYM |
RA Capital Management, L.P. | 13,176,403 47.700% |
13,332 (+0.10%) |
Filing History |
| 2023-11-13 5:13 pm Unchanged |
2023-08-10 | 13D | Climb Bio, Inc. CLYM |
AI ETI LLC | 5,009,400 18.500% |
0 (Unchanged) |
Filing History |
| 2023-04-10 5:01 pm Purchase |
2023-04-06 | 13D | Climb Bio, Inc. CLYM |
RA Capital Management, L.P. | 13,163,071 48.800% |
11,112 (+0.08%) |
Filing History |
| 2023-03-08 4:00 pm Purchase |
2022-12-31 | 13G | Climb Bio, Inc. CLYM |
Intermediate Capital Group plc | 2,002,563 7.500% |
2,002,563 (New Position) |
Filing History |
| 2023-02-14 2:22 pm Sale |
2022-12-31 | 13G | Climb Bio, Inc. CLYM |
Samlyn Capital, LLC | 0 0.000% |
-2,128,202 (Position Closed) |
Filing History |
| 2023-02-08 4:35 pm Purchase |
2023-02-08 | 13G | Climb Bio, Inc. CLYM |
BML Investment Partners, L.P. | 1,897,614 7.100% |
158,236 (+9.10%) |
Filing History |
| 2022-09-22 5:02 pm Purchase |
2021-12-31 | 13G | Climb Bio, Inc. CLYM |
ICG Life Sciences SCSp | 2,002,563 7.500% |
2,002,563 (New Position) |
Filing History |